Neurocrine ending development of luvadaxistat amid failed study Source: Seekingalpha
Browsing: study
Neurocrine ending development of luvadaxistat amid failed study Source: Seekingalpha
Devonyu Neurocrine Biosciences (NASDAQ:NBIX) has halted development of luvadaxistat as a result of disappointing outcomes from a Phase 2 study of the drug within the remedy…
Merck’s HPV vaccine meets key goals in Japanese study Source: Seekingalpha
Centessa stock jumps 10% on Phase 1 narcolepsy study for ORX750 Source: (*1*)
Centessa stock jumps 10% on Phase 1 narcolepsy study for ORX750 Source: (*1*)
Centessa stock jumps 10% on Phase 1 narcolepsy study for ORX750 Source: (*1*)
Fulcrum rises after BofA upgrades rating on chance of FSHD study success Source: Seekingalpha
J&J Rybrevant/Lazcluze study shows superiority over Tagrisso Source: Seekingalpha
Fulcrum rises after BofA upgrades rating on chance of FSHD study success Source: Seekingalpha